REVOLVING CREDIT AGREEMENTCelgene Corp /De/ • October 19th, 2015 • Pharmaceutical preparations
Celgene Corporation, a Delaware corporation (the “Borrower”), has requested JPMorgan Chase Bank, N.A. (the “Lender”) to extend credit to enable it to obtain advances (the “Advances”) in U.S. dollars from time to time during the term of this Agreement in an aggregate principal amount at any time outstanding not to exceed $1,000,000,000, and the Lender has agreed to make Advances on the terms and subject to the conditions set forth or incorporated by reference herein. Accordingly, the parties hereto agree as follows:
